发明名称 |
USE OF ALGINATE OLIGOMERS AS BLOOD ANTICOAGULANTS |
摘要 |
The disclosure relates to an alginate oligomer of 2 to 75 monomer residues, wherein said monomer residues do not carry a sulphate group, for use as a blood anticoagulant in clinical and non-clinical applications, including in vivo, ex vivo and in vitro contexts. The invention further provides for the use of such an alginate oligomer in preparing a product or device having a reduced capacity to promote blood coagulation, wherein said alginate oligomer is provided at or on a surface of said product or device. Such products and devices form a further aspect of the invention. |
申请公布号 |
US2016331777(A1) |
申请公布日期 |
2016.11.17 |
申请号 |
US201415106196 |
申请日期 |
2014.12.19 |
申请人 |
ALGIPHARMA AS |
发明人 |
DESSEN Arne;RYE Philip |
分类号 |
A61K31/734;A61M1/36;A61L33/08 |
主分类号 |
A61K31/734 |
代理机构 |
|
代理人 |
|
主权项 |
1. An in vitro or ex vivo method for the prevention or inhibition of blood coagulation, said method comprising contacting a composition comprising blood plasma or a material with which said composition is, or may be, in contact, with an alginate oligomer of 2 to 75 monomer residues, wherein said monomer residues do not carry a sulphate group. |
地址 |
Sandvika NO |